The Tobramycin Study

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

March 31, 2005

Conditions
NeutropeniaFeverCancer
Interventions
DRUG

Tobramycin once a day

All Listed Sponsors
collaborator

The National Institute of Health, Oslo

UNKNOWN

collaborator

Ullevaal University Hospital

OTHER

collaborator

Sorlandet Hospital HF

OTHER_GOV

collaborator

Sykehuset Buskerud

UNKNOWN

collaborator

Sentralsjukehuset i Rogaland

UNKNOWN

collaborator

Sykehuset Innlandet HF

OTHER

collaborator

Sentralsjukehuset i Hedemark

UNKNOWN

collaborator

The Hospital of Vestfold

OTHER

collaborator

Sykehuset Asker og Baerum

OTHER

lead

Oslo University Hospital

OTHER

NCT00257790 - The Tobramycin Study | Biotech Hunter | Biotech Hunter